Literature DB >> 3233793

The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.

P C Johnston1, I H Stevenson, D S Hewick.   

Abstract

An enzyme-linked immunosorbent assay was developed for the measurement of sheep digoxin-specific immunoglobulin G and Fab fragments. With the latter, two preparations were examined, one available commercially (Digibind, Wellcome) and one prepared by ourselves (DSFab). The assay exhibited a greater sensitivity towards immunoglobulin G compared with Digibind and DSFab, presumably because the Fab preparations lacked some of the sheep-specific antigens present on the whole antibody molecule. The assay was used subsequently to examine the disposition of the antibody preparations after injection of 1 mg/kg i.v. into anaesthetised bile duct-cannulated rats. The plasma distribution half-lives (1.8-3.3 min) were similar for all three preparations, but while plasma elimination half-life values for Digibind and DSFab were much the same (110-115 min), that for immunoglobulin G was longer (425 min). The shorter half-life values for Fab fragments were linked to a rate of urinary elimination 10-20 fold faster. No antibody excretion in the bile was detected. The apparent volume of distribution of immunoglobulin G was 35 ml/kg, indicating that the whole antibody was largely confined to the plasma space. The volume of distribution for Digibind or DSFab (about 46 ml/kg) was not significantly larger than that for immunoglobulin G and much smaller than the extracellular fluid volume, which was measured as 305 ml/kg. Thus the distribution of sheep Fab fragments in the rat markedly differs from that in the baboon (Smith et al., 1979) where the apparent volume of distribution approximates to the extracellular fluid volume.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233793      PMCID: PMC1542035     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Antidigoxin antibodies in eclampsia.

Authors:  R C Goodlin
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

2.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

Authors:  R D Brown; J E Manno
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

5.  Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.

Authors:  T W Smith; B L Lloyd; N Spicer; E Haber
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

7.  The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments.

Authors:  R D Wochner; W Strober; T A Waldmann
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

8.  Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments.

Authors:  B L Lloyd; T W Smith
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

9.  Body fluid volumes in the spontaneously hypertensive rat.

Authors:  M Bianchi; G Bellini; H Hessan; K E Kim; C Swartz; M Fernandes
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

10.  The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin.

Authors:  J Curd; T W Smith; J C Jaton; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

View more
  2 in total

1.  Kinetics of digoxin and anti-digoxin antibody fragments during treatment of digoxin toxicity.

Authors:  A J Sinclair; D S Hewick; P C Johnston; I H Stevenson; M Lemon
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

2.  Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.

Authors:  C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; J M Scherrmann
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.